Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical.

Slides:

Advertisements

Similar presentations

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction

Advertisements

The “occasional open heart surgeon” revisited

Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts Robert H. Habib, PhD,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

A wolf in sheep's clothing

Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation Irving L. Kron, MD, Judy Hung, MD, Jessica.

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

A heart team’s perspective on interventional mitral valve repair: Percutaneous clip implantation as an important adjunct to a surgical mitral valve program.

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Standardizing definitions for hybrid coronary revascularization

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction

Right internal thoracic artery or saphenous vein grafting

POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation:

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Juan A. Crestanello, MD, Richard C. Daly, MD

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: Early results Ho Young.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Michael E. Halkos, MD, MSc, Henry A

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

Multilevel data analysis: What? Why? How?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Patrick T. O'Gara, MD, MACC, FAHA, Thoralf M. Sundt, MD, Michael A

Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial Umberto Benedetto, MD, PhD, Douglas G. Altman,

The lord of the rings Antonio Miceli, MD, PhD

Igor E. Konstantinov, MD, PhD, FRACS

Jared P. Beller, MD, Irving L. Kron, MD

Uniform standards do not apply to readmission following coronary artery bypass surgery: A multi-institutional study Robert Lancey, MD, Paul Kurlansky,

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Baseline left ventricular function and surgical annular stiffening to predict outcome and reverse left ventricular remodeling after undersized annuloplasty.

Louis P. Perrault, MD, PhD, Alan J. Moskowitz, MD, Irving L

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: One-year angiographic results.

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome Kevin G. Soucy, PhD, Steven.

Left ventricular assist device therapy in a patient with hearing and speech disabilities Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,

Innovation and science: The future of valve design

Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.

For everything there is a season

Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction Joseph J.

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Replicating the success of mitral valve repair in the aortic valve

The Ross procedure: Time to reevaluate the guidelines

Manuel J. Antunes, MD, PhD, DSc

Commentary: Three-dimensional P3 tethering angle at the heart of future surgical decision making in ischemic mitral regurgitation Wobbe Bouma, MD, PhD,

Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting.

Innovation in cardiothoracic surgical training

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

Blood Transfusion and Infection After Cardiac Surgery

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

First in line for robotic surgery: Would you want to know?

Apples remain apples NO matter what

Gianluca Torregrossa, MD, John D. Puskas, MD, MSc, FACS, FACC

The relationship between perioperative temperature and adverse outcomes after off- pump coronary artery bypass graft surgery Edward L. Hannan, PhD, Zaza.

The evolution of cardiothoracic critical care

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Intraoperative endocardial ultrasonography: Improving safety in mitral valve surgery Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

Presentation transcript:

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network Peter K. Smith, MD, Robert E. Michler, MD, Y. Joseph Woo, MD, John H. Alexander, MD, MHS, John D. Puskas, MD, Michael K. Parides, PhD, Rebecca T. Hahn, MD, Judson B. Williams, MD, John M. Dent, MD, T. Bruce Ferguson, MD, Ellen Moquete, RN, BSN, Eric A. Rose, MD, Pierre Pagé, MD, Neal O. Jeffries, PhD, Patrick T. O’Gara, MD, Deborah D. Ascheim, MD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 1, Pages 111-117.e1 (January 2012) DOI: 10.1016/j.jtcvs.2011.05.006 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Study design flow chart. MR, Mitral regurgitation; CABG, coronary artery bypass grafting; LVESVI, left ventricular systolic volume index; LOS, length of stay; LVEF, left ventricular ejection fraction; AE’s, adverse events. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 111-117.e1DOI: (10.1016/j.jtcvs.2011.05.006) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions